OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities
Nikolaos G. Frangogiannis
Molecular Aspects of Medicine (2018) Vol. 65, pp. 70-99
Open Access | Times Cited: 672

Showing 1-25 of 672 citing articles:

Transforming growth factor–β in tissue fibrosis
Nikolaos G. Frangogiannis
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 3
Open Access | Times Cited: 813

Cardiac fibrosis
Nikolaos G. Frangogiannis
Cardiovascular Research (2020) Vol. 117, Iss. 6, pp. 1450-1488
Open Access | Times Cited: 710

The Extracellular Matrix in Ischemic and Nonischemic Heart Failure
Nikolaos G. Frangogiannis
Circulation Research (2019) Vol. 125, Iss. 1, pp. 117-146
Open Access | Times Cited: 404

Inflammation and fibrosis in murine models of heart failure
Lucas Bacmeister, Michael Schwarzl, Svenja Warnke, et al.
Basic Research in Cardiology (2019) Vol. 114, Iss. 3
Closed Access | Times Cited: 317

Fibroblasts in the Infarcted, Remodeling, and Failing Heart
Claudio Humeres, Nikolaos G. Frangogiannis
JACC Basic to Translational Science (2019) Vol. 4, Iss. 3, pp. 449-467
Open Access | Times Cited: 313

Myofibroblasts and Fibrosis
Andrew Gibb, Michael P. Lazaropoulos, John W. Elrod
Circulation Research (2020) Vol. 127, Iss. 3, pp. 427-447
Open Access | Times Cited: 287

Role of Cardiac Macrophages on Cardiac Inflammation, Fibrosis and Tissue Repair
William P. Lafuse, Daniel J. Wozniak, Murugesan V. S. Rajaram
Cells (2020) Vol. 10, Iss. 1, pp. 51-51
Open Access | Times Cited: 256

Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches
Begoña López, Susana Ravassa, María U. Moreno, et al.
Nature Reviews Cardiology (2021) Vol. 18, Iss. 7, pp. 479-498
Closed Access | Times Cited: 220

The myofibroblast at a glance
Pardis Pakshir, Nina Noskovičová, Monika Lodyga, et al.
Journal of Cell Science (2020) Vol. 133, Iss. 13
Open Access | Times Cited: 217

Cardiovascular Aging and Heart Failure
Filippos Triposkiadis, Αndrew Xanthopoulos, Javed Butler
Journal of the American College of Cardiology (2019) Vol. 74, Iss. 6, pp. 804-813
Open Access | Times Cited: 208

TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering
Jin Ma, Gonzalo Sánchez‐Duffhues, Marie‐José Goumans, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 186

Polystyrene microplastics cause cardiac fibrosis by activating Wnt/β-catenin signaling pathway and promoting cardiomyocyte apoptosis in rats
Zekang Li, Shuxiang Zhu, Qian Liu, et al.
Environmental Pollution (2020) Vol. 265, pp. 115025-115025
Closed Access | Times Cited: 177

Immune Cells and Immunotherapy for Cardiac Injury and Repair
Joel G. Rurik, Haig Aghajanian, Jonathan A. Epstein
Circulation Research (2021) Vol. 128, Iss. 11, pp. 1766-1779
Open Access | Times Cited: 173

The quiescent endothelium: signalling pathways regulating organ-specific endothelial normalcy
Nicolas Ricard, Sabine Bailly, Christophe Guignabert, et al.
Nature Reviews Cardiology (2021) Vol. 18, Iss. 8, pp. 565-580
Open Access | Times Cited: 164

Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities
Ioanna Andreadou, Héctor A. Cabrera-Fuentes, Yvan Devaux, et al.
Cardiovascular Research (2019) Vol. 115, Iss. 7, pp. 1117-1130
Open Access | Times Cited: 161

Hif-1a suppresses ROS-induced proliferation of cardiac fibroblasts following myocardial infarction
Vaibhao Janbandhu, Vikram J. Tallapragada, Ralph Patrick, et al.
Cell stem cell (2021) Vol. 29, Iss. 2, pp. 281-297.e12
Open Access | Times Cited: 143

Micro- and nanoplastics: A new cardiovascular risk factor?
Xiaoqi Zhu, Chuanxuan Wang, Xiaoyu Duan, et al.
Environment International (2022) Vol. 171, pp. 107662-107662
Open Access | Times Cited: 139

The inflammatory speech of fibroblasts
Ronen Schuster, Jason S. Rockel, Mohit Kapoor, et al.
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 126-146
Closed Access | Times Cited: 130

The Pathogenesis of Cardiac Fibrosis: A Review of Recent Progress
Kazuaki Maruyama, Kyoko Imanaka‐Yoshida
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2617-2617
Open Access | Times Cited: 112

Multipotent stromal cells: One name, multiple identities
H. S. Soliman, Marine Théret, R. Wilder Scott, et al.
Cell stem cell (2021) Vol. 28, Iss. 10, pp. 1690-1707
Open Access | Times Cited: 109

Pivotal Role of TGF-β/Smad Signaling in Cardiac Fibrosis: Non-coding RNAs as Effectual Players
Somayeh Saadat, Mahdi Noureddini, Maryam Mahjoubin‐Tehran, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 7
Open Access | Times Cited: 108

Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities
Lili Ren, Xiaojun Li, Tingting Duan, et al.
Chemico-Biological Interactions (2022) Vol. 369, pp. 110289-110289
Closed Access | Times Cited: 81

The Role of Interleukin-6 Family Members in Cardiovascular Diseases
Yongqi Feng, Di Ye, Zhen Wang, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 74

Page 1 - Next Page

Scroll to top